KalVista Pharmaceuticals, Inc. KALV

Set alert

27.00 USD 0.00 (+0.00%)

At closeJun 10, 2026, 4:00 PM EDT

26.99 -0.01 -0.04%

After hours · Jun 10, 4:00 PM ET

26.98 Day range 27.00

9.83 52-week range 27.00

Held by insiders 1.72%

Held by institutions 136.88%

Float held by institutions 139.27%

Institutions 259

Top institutional holders
Holder	% held	Shares	Value	Reported
Venrock Adviser, LLC	12.16%	6,474,485	174.81M	Mar 30, 2026
Frazier Life Sciences Management, L.P.	9.32%	4,961,108	133.95M	Mar 30, 2026
Suvretta Capital Management, LLC	8.96%	4,768,712	128.76M	Mar 30, 2026
Tang Capital Management, LLC	8.59%	4,573,530	123.49M	Mar 30, 2026
Blackrock Inc.	7.13%	3,795,897	102.49M	Mar 30, 2026
SilverArc Capital Management, LLC	5.40%	2,876,407	77.66M	Mar 30, 2026

Top mutual fund holders
Holder	% held	Shares	Value	Reported
SmallCap World Fund Inc	5.28%	2,808,583	75.83M	Mar 30, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund	2.54%	1,349,851	36.45M	Mar 30, 2026
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF	2.26%	1,204,868	32.53M	Apr 29, 2026
iShares Trust-iShares Russell 2000 ETF	1.70%	905,839	24.46M	Apr 29, 2026
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund	0.83%	439,451	11.87M	Mar 30, 2026
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund	0.71%	375,708	10.14M	Feb 27, 2026

KALV insiders
Insider	Relation	Latest transaction	Date	Shares held
AUDHYA PAUL K	Officer	Sale	May 25, 2026	150,260
PALLEIKO BENJAMIN L	Chief Executive Officer	Sale	May 21, 2026	479,989
PIEKOS BRIAN	Chief Financial Officer	Sale	May 21, 2026	21,661
SWEENY NICOLE	Officer	Sale	May 25, 2026	59,291
VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P.	Beneficial Owner of more than 10% of a Class of Security	Sale	Mar 25, 2026	0
YEA CHRISTOPHER M	Officer	Sale	May 26, 2026	229,918

Held by funds